MGRX icon

Mangoceuticals

9 hedge funds and large institutions have $221K invested in Mangoceuticals in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
ACA
1
Ackerman Capital Advisors
Texas
$83.5K -$57.4K -23,724 -41%
VF
2
Virtu Financial
New York
$50K +$46.9K +19,245 +1,532%
HF
3
HRT Financial
New York
$32K +$32K +13,472 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$29.2K +$7.89K +3,248 +37%
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$11.1K +$11.1K +4,600 New
TRCT
6
Tower Research Capital (TRC)
New York
$6.37K +$6.37K +2,633 New
SPIA
7
Steward Partners Investment Advisory
New York
$5.07K +$2 +1 +0%
UBS Group
8
UBS Group
Switzerland
$3.69K +$3.69K +1,524 New
Bank of America
9
Bank of America
North Carolina
$27 +$2 +1 +10%
MCG
10
McCollum Christoferson Group
New York
-$20.2K -5,720 Closed
TSS
11
Two Sigma Securities
New York
-$8.93K -2,523 Closed
XT
12
XTX Topco
Cayman Islands
-$6.8K -1,922 Closed
Creative Planning
13
Creative Planning
Kansas
-$4.72K -1,333 Closed
CAPTRUST Financial Advisors
14
CAPTRUST Financial Advisors
North Carolina
-$4.03K -1,138 Closed
SG
15
StoneX Group
New York
-$3.22K -910 Closed
Goldman Sachs
16
Goldman Sachs
New York
-$2.4K -679 Closed